NO20084987L - Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel - Google Patents

Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel

Info

Publication number
NO20084987L
NO20084987L NO20084987A NO20084987A NO20084987L NO 20084987 L NO20084987 L NO 20084987L NO 20084987 A NO20084987 A NO 20084987A NO 20084987 A NO20084987 A NO 20084987A NO 20084987 L NO20084987 L NO 20084987L
Authority
NO
Norway
Prior art keywords
nicotine
trometamol
pharmaceutical product
buffering agent
delivery
Prior art date
Application number
NO20084987A
Other languages
English (en)
Norwegian (no)
Inventor
Per Steen
Darek Dymitrowics
Asa Waltermo
Roland Olsson
Katarina Lindell
Original Assignee
Mcneil Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38694149&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20084987(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mcneil Ab filed Critical Mcneil Ab
Publication of NO20084987L publication Critical patent/NO20084987L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20084987A 2006-05-16 2008-11-27 Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel NO20084987L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0601090 2006-05-16
PCT/SE2007/000365 WO2007133141A1 (en) 2006-05-16 2007-04-18 Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent

Publications (1)

Publication Number Publication Date
NO20084987L true NO20084987L (no) 2009-02-16

Family

ID=38694149

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084987A NO20084987L (no) 2006-05-16 2008-11-27 Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel

Country Status (16)

Country Link
US (1) US20070269492A1 (zh)
EP (1) EP2023928A4 (zh)
JP (1) JP5254213B2 (zh)
KR (1) KR101414063B1 (zh)
CN (1) CN101472591A (zh)
AR (1) AR060931A1 (zh)
AU (1) AU2007250589B2 (zh)
BR (1) BRPI0712068A2 (zh)
CA (1) CA2652500C (zh)
MX (1) MX2008014726A (zh)
NO (1) NO20084987L (zh)
NZ (1) NZ572758A (zh)
RU (1) RU2448707C2 (zh)
TW (1) TW200810755A (zh)
WO (1) WO2007133141A1 (zh)
ZA (1) ZA200810618B (zh)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
GB2468424B (en) * 2007-04-02 2011-11-09 Parkinson S Inst Methods and compositions for reduction of side effects of therapeutic treatments
CN103977003A (zh) * 2007-04-02 2014-08-13 帕金森氏病研究院 用于降低治疗的副作用的方法和组合物
US20080286341A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
AU2013219211B2 (en) * 2008-05-01 2016-05-12 Glaxosmithkline Llc Nicotine lozenge compositions
CL2009001025A1 (es) * 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
ES2401912T3 (es) * 2008-09-17 2013-04-25 Siegfried Ltd. Granulado que contiene nicotina
CA2737307A1 (en) 2008-10-14 2010-04-22 Mcneil Ab Multi portion intra-oral dosage form and use thereof
SI2198865T1 (sl) * 2008-12-19 2012-02-29 Siegfried Ltd Nikotin vsebujoč proizvod
US20100247586A1 (en) * 2009-03-27 2010-09-30 Andreas Hugerth Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
WO2010145653A1 (en) * 2009-06-19 2010-12-23 Fertin Pharma A/S Buffered gum base for high ph release
CN102770138B (zh) * 2010-02-18 2015-12-09 J·V·达卡 含有尼古丁的软凝胶锭剂
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US20130177646A1 (en) * 2012-01-05 2013-07-11 Mcneil Ab Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
FR2993778B1 (fr) * 2012-07-30 2016-06-17 Pf Medicament Pastilles a cinetiques multiples de liberation de principes actifs
CN102926277B (zh) * 2012-11-14 2015-05-20 湖南中烟工业有限责任公司 一种β-环糊精-g-乳酸共聚物的应用
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
US20170172995A1 (en) * 2015-09-08 2017-06-22 Venkateswara Rao Repaka Pharmaceutical compositions of Nicotine and process for preparation thereof
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
US11285306B2 (en) 2017-01-06 2022-03-29 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
EP3720418B1 (en) * 2017-12-08 2021-08-04 Fertin Pharma A/S Nicotine tablet
AU2019279884A1 (en) 2018-05-29 2020-12-10 Morningside Venture Investments Limited Drug delivery methods and systems
MX2021000466A (es) 2018-07-13 2021-03-25 Mcneil Ab Goma de mascar que comprende nicotina.
EP4090314A1 (en) 2020-01-15 2022-11-23 McNeil AB Lozenge
WO2023067087A1 (en) * 2021-10-21 2023-04-27 Mcneil Ab Nicotine chewing gum

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3877468A (en) * 1970-07-22 1975-04-15 Leo Ab Chewable tobacco substitute composition
US3901248A (en) * 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US3845217A (en) * 1972-11-16 1974-10-29 Helsingborg L Ab Buffered smoking substitute compositions
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
US5783207A (en) * 1985-05-01 1998-07-21 University Of Utah Research Foundation Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
GB8615676D0 (en) * 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
US5004651A (en) * 1989-01-24 1991-04-02 Abbott Laboratories Stabilizing system for solid dosage forms
US5824334A (en) * 1989-09-05 1998-10-20 University Of Utah Research Foundation Tobacco substitute
US5167242A (en) * 1990-06-08 1992-12-01 Kabi Pharmacia Aktiebolaq Nicotine-impermeable container and method of fabricating the same
EP0620706A1 (en) * 1992-01-06 1994-10-26 E.I. Du Pont De Nemours And Company Tablet formulation with internal desiccant
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
US5889028A (en) * 1996-02-09 1999-03-30 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
US5810081A (en) * 1997-02-24 1998-09-22 Cobb; Delwin E. Wear structure for bore hole separation device
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
US20040037879A1 (en) * 2001-11-02 2004-02-26 Adusumilli Prasad S. Oral controlled release forms useful for reducing or preventing nicotine cravings
US20040137054A1 (en) * 2002-05-03 2004-07-15 Alexandra Hager Stable pharmaceutical formulation for a combination of a statin and an ace-inhibitors
WO2003101431A1 (en) * 2002-06-04 2003-12-11 J.B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical composition for controlled drug delivery system
US20030049307A1 (en) * 2002-08-15 2003-03-13 Gyurik Robert J. Pharmaceutical composition
US20040052851A1 (en) * 2002-09-16 2004-03-18 Graff Allan H. Modified release oral dosage form

Also Published As

Publication number Publication date
EP2023928A1 (en) 2009-02-18
RU2008149508A (ru) 2010-06-27
JP2009537514A (ja) 2009-10-29
CA2652500A1 (en) 2007-11-22
WO2007133141A1 (en) 2007-11-22
KR20090024161A (ko) 2009-03-06
CA2652500C (en) 2014-07-29
TW200810755A (en) 2008-03-01
AU2007250589B2 (en) 2011-04-14
BRPI0712068A2 (pt) 2012-01-17
NZ572758A (en) 2011-01-28
MX2008014726A (es) 2009-02-04
JP5254213B2 (ja) 2013-08-07
AR060931A1 (es) 2008-07-23
ZA200810618B (en) 2010-02-24
CN101472591A (zh) 2009-07-01
RU2448707C2 (ru) 2012-04-27
US20070269492A1 (en) 2007-11-22
EP2023928A4 (en) 2012-08-29
AU2007250589A1 (en) 2007-11-22
KR101414063B1 (ko) 2014-07-18

Similar Documents

Publication Publication Date Title
NO20084987L (no) Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel
MX2009012484A (es) Formulacion de nicotina oral recubierta regulada con aminoacido.
NO20084992L (no) Farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel
NO20084752L (no) Konjugater av aziridinayl-epotilonanaloger og farmasoytiske sammensetninger som inneholder disse
EP4342312A3 (en) Tobacco composition
RS54328B1 (en) MULTIPLE TREATMENT OF LAKVINIMOD SCLEROSIS
WO2008069970A3 (en) Nicotine formulations, kits and systems and methods for their use
RS51280B (sr) Novi derivati hidantoina za tretman obstruktivnih bolesti dišnih puteva
MX2009011862A (es) Composiciones farmaceuticas de administracion oronasofaringea de agonistas de la dopamina para la prevencion/alivio y/o tratamiento del desorden de miembros inquietos.
MX2008010172A (es) Suministro pulmonar de inhibidor de proteinasa alafa-i.
EA201170520A1 (ru) Ингибитор p38 mapk-киназы
MX2007004495A (es) Composiciones y procedimientos para la administracion intranasal, bucal, sublingual y pulmonar de vareniclina.
MEP27308A (en) Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual
MX2010003923A (es) Formulacion farmaceutica de valsartan.
BRPI0922796A2 (pt) Comprimido farmacêutico para administração por via oral e método de fabricação do mesmo
BR112021018054A2 (pt) Composição de tabaco, método para produção da composição de tabaco, uso de uma composição de tabaco, artigo para uso em um sistema de fornecimento de aerossol e sistema
MX2010009623A (es) Derivados de 1-bencil-3-hidroximetilindazol novedosos y su uso en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
NO20075111L (no) Farmasoytisk sammensetning
UA96076C2 (en) Use of trans-clomiphene
NO20090407L (no) Aerosolformulering for inhalering av beta agonister
NO20084826L (no) Ny administrasjonsform av racecadotril
MX2010009625A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
NO20090605L (no) Metode for inhibering av respirasjonsdepresjon ved bruk av positive allosteriske AMPA reseptormodulatorer
UA106098C2 (uk) Аерозольна композиція для хозл
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application